Variant position: 29 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 545 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human RLLRLHRTEIAVAVDSAFPL LHALADHDVVPEDKFQETLHL
Mouse RLLRLHRTEIAVAIDSAFPL LHALADHDVVPEDKFQETLRL
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 545 Autoimmune regulator
1 – 105 HSR
1 – 292 MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLH -> MWLVYSSGAPGTQQPARNRVFFPIGMAPGGVCWRPDGWGTGGQGRISGPGSMGAGQRLGSSGTQRCCWGSCFGKEVALRRVLHPS. In isoform 2, isoform 3 and isoform 4.
28 – 29 LL -> PP. Loss of doted nuclear location, forms nuclear smears. Loss of transactivation activity on target genes transcription.
APECED-causing mutations in AIRE reveal the functional domains of the protein.
Halonen M.; Kangas H.; Rueppell T.; Ilmarinen T.; Ollila J.; Kolmer M.; Vihinen M.; Palvimo J.; Saarela J.; Ulmanen I.; Eskelin P.;
Hum. Mutat. 23:245-257(2004)
Cited for: SUBCELLULAR LOCATION; HOMOOLIGOMERIZATION; CHARACTERIZATION OF VARIANTS APS1 LEU-15; MET-16; VAL-21; PRO-28; PRO-29; ARG-78; LEU-80; GLU-83; CYS-90; ARG-93; TRP-228 AND GLN-326;
Distinct clinical phenotype and immunoreactivity in Japanese siblings with autoimmune polyglandular syndrome type 1 (APS-1) associated with compound heterozygous novel AIRE gene mutations.
Kogawa K.; Kudoh J.; Nagafuchi S.; Ohga S.; Katsuta H.; Ishibashi H.; Harada M.; Hara T.; Shimizu N.;
Clin. Immunol. 103:277-283(2002)
Cited for: VARIANT APS1 PRO-29;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.